News Pharmesis International Ltd.

Equities

BFK

SG1BH6000003

Market Closed - Singapore S.E. Other stock markets 12:59:02 2024-05-08 am EDT			5-day change	1st Jan Change
0.105 ^SGD	-5.41%		0.00%	+7.14%

Apr. 30	Pharmesis International Ltd. Approves the Appointment of Seow Yong Teng as Lead Independent Director	CI
Apr. 30	Pharmesis International Ltd. Announces Re-Designation of Chew Heng Ching to Non-Independent Non-Executive Chairman	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharmesis International : Sustainablity Report 2023	May. 05	PU
Pharmesis International Ltd. Approves the Appointment of Seow Yong Teng as Lead Independent Director	Apr. 30	CI
Pharmesis International Ltd. Announces Re-Designation of Chew Heng Ching to Non-Independent Non-Executive Chairman	Apr. 30	CI
Pharmesis International Ltd. Announces Retirement of Lin Yimin as Member of Audit Committee	Apr. 29	CI
Pharmesis’ Attributable Loss for 2023 Widens	Apr. 14	MT
Pharmesis International Ltd. Announces the Retirement of Ms. Lin Yimin as a Director	Apr. 14	CI
Pharmesis Launches New Product Line	Mar. 26	MT
Pharmesis International Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Pharmesis International Ltd. Provides Earnings Guidance for the Six Months and Full Year Ended 31 December 2023	Feb. 28	CI
Pharmesis International Ltd. Announces Changes to the Composition of the Board and Board Committees	23-09-29	CI
Pharmesis International Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-14	CI
Pharmesis International Flags Losses for H1	23-08-09	MT
Pharmesis International Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2023	23-08-08	CI
Pharmesis International Ltd. Announces Management Resignations	23-07-31	CI
Pharmesis International Ltd. Appoints Lin Yimin as Non-Independent Non-Executive Director and A Member of Audit Committee	23-07-31	CI
Pharmesis International Ltd. Announces Temporary Work Stoppages at its Manufacturing Facilities Located in Gulin County, Luzhou City, Sichuan Province	23-07-27	CI
Pharmesis International Issues 4.6 Million Shares to Two Subscribers	23-04-05	MT
Pharmesis International Gets Regulatory Nod to List 4.6 Million Shares	23-03-29	MT
Pharmesis International to Issue 4.6 Million Shares to Two Subscribers	23-03-21	MT
Pharmesis International Expects Loss in H2, FY22	23-02-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pharmesis International Ltd.

Equities

BFK

SG1BH6000003

Summary

Filters